A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Dynagenix in Post-Exercise Musculoskeletal Function Recovery in Healthy Subjects

Study Demonstrates Improved Supports Muscle and Joint Comfort with Enhanced Recovery and Strength After Exercise

The strong anti-inflammatory properties of PLT’s Boswellia serrata-based ingredients have been well-established through more than a decade of peer-reviewed research. Looking to extend the understanding of this ingredient on the human body, PLT’s clinical trial design used a model that would stress both muscles and joints to demonstrate Dynagenix’s efficacy.

In the trial, 50 recreationally active men (age 25-40) were studied for their response to eccentric exercise-related Delayed-Onset Muscle Soreness using 60mg of Dynagenix versus a placebo. The supplementation period was 10 days with eccentric exercise intervention on day 7. Testing occurred at baseline and on days 7-10.